Eli Lilly & Co.

90
Strong Buy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5324571083
USD
1,001.35
-7.04 (-0.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
65,179.00
45,042.00
34,124.00
28,541.00
28,318.00
24,539.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
65,179.00
45,042.00
34,124.00
28,541.00
28,318.00
24,539.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
780.00
485.00
331.00
339.00
359.00
General and Administration Expenses
11,094.00
8,593.00
7,403.00
6,440.00
6,431.00
6,121.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
35,483.00
28,002.00
23,798.00
20,261.00
20,770.00
17,690.00
Operating Profit (PBDIT) excl Other Income
29,696.00
17,039.00
10,325.00
8,280.00
7,548.00
6,849.00
Other Income
-82.00
943.00
500.00
210.00
789.00
1,305.00
Operating Profit (PBDIT)
31,611.00
19,749.00
12,353.00
10,013.00
9,885.00
9,478.00
Interest
0.00
780.00
485.00
331.00
339.00
359.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
1,997.00
1,766.00
1,527.00
1,522.00
1,547.00
1,323.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
25,731.00
12,680.00
6,554.00
6,806.00
6,155.00
7,229.00
Provision for Tax
5,091.00
2,090.00
1,314.00
561.00
573.00
1,036.00
Profit After Tax
20,640.00
10,590.00
5,240.00
6,244.00
5,581.00
6,193.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
22.95
11.71
5.80
6.90
6.12
6.79
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 44.70% vs 32.00% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 74.27% vs 65.03% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -100.00% vs 60.65% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 94.90% vs 102.08% in Dec 2024

Compare Profit and Loss Results of Eli Lilly & Co.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
65,179.00
94,178.00
-28,999.00
-30.79%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
65,179.00
94,178.00
-28,999.00
-30.79%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
1,490.00
-1,490.00
-100.00%
General and Administration Expenses
11,094.00
23,676.00
-12,582.00
-53.14%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
35,483.00
68,054.00
-32,571.00
-47.86%
Operating Profit (PBDIT) excl Other Income
29,696.00
26,124.00
3,572.00
13.67%
Other Income
-82.00
2,523.00
-2,605.00
-103.25%
Operating Profit (PBDIT)
31,611.00
36,150.00
-4,539.00
-12.56%
Interest
0.00
1,490.00
-1,490.00
-100.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
1,997.00
7,503.00
-5,506.00
-73.38%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
25,731.00
32,581.00
-6,850.00
-21.02%
Provision for Tax
5,091.00
5,777.00
-686.00
-11.87%
Profit After Tax
20,640.00
26,804.00
-6,164.00
-23.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
22.9512
11.0332
11.92
108.02%
Profit And Loss - Net Sales
Net Sales 65,179.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 44.70% vs 32.00% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29,696.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 74.27% vs 65.03% in Dec 2024

Profit And Loss - Interest
Interest 0.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -100.00% vs 60.65% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 20,640.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 94.90% vs 102.08% in Dec 2024